S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.45%)
AAPL   263.19 (-1.16%)
FB   197.51 (-0.91%)
MSFT   149.62 (-0.51%)
GOOGL   1,301.86 (-0.82%)
AMZN   1,745.53 (-0.41%)
CGC   17.64 (+15.14%)
NVDA   211.18 (+1.53%)
MU   45.57 (-2.17%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
TSLA   352.22 (-2.03%)
T   37.18 (-2.16%)
AMD   40.98 (-0.75%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
PRI   131.52 (-0.09%)
NFLX   305.16 (+0.85%)
BAC   32.69 (-0.76%)
GILD   64.88 (-0.18%)
DIS   146.93 (-0.98%)
S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.45%)
AAPL   263.19 (-1.16%)
FB   197.51 (-0.91%)
MSFT   149.62 (-0.51%)
GOOGL   1,301.86 (-0.82%)
AMZN   1,745.53 (-0.41%)
CGC   17.64 (+15.14%)
NVDA   211.18 (+1.53%)
MU   45.57 (-2.17%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
TSLA   352.22 (-2.03%)
T   37.18 (-2.16%)
AMD   40.98 (-0.75%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
PRI   131.52 (-0.09%)
NFLX   305.16 (+0.85%)
BAC   32.69 (-0.76%)
GILD   64.88 (-0.18%)
DIS   146.93 (-0.98%)
S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.45%)
AAPL   263.19 (-1.16%)
FB   197.51 (-0.91%)
MSFT   149.62 (-0.51%)
GOOGL   1,301.86 (-0.82%)
AMZN   1,745.53 (-0.41%)
CGC   17.64 (+15.14%)
NVDA   211.18 (+1.53%)
MU   45.57 (-2.17%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
TSLA   352.22 (-2.03%)
T   37.18 (-2.16%)
AMD   40.98 (-0.75%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
PRI   131.52 (-0.09%)
NFLX   305.16 (+0.85%)
BAC   32.69 (-0.76%)
GILD   64.88 (-0.18%)
DIS   146.93 (-0.98%)
S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.45%)
AAPL   263.19 (-1.16%)
FB   197.51 (-0.91%)
MSFT   149.62 (-0.51%)
GOOGL   1,301.86 (-0.82%)
AMZN   1,745.53 (-0.41%)
CGC   17.64 (+15.14%)
NVDA   211.18 (+1.53%)
MU   45.57 (-2.17%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
TSLA   352.22 (-2.03%)
T   37.18 (-2.16%)
AMD   40.98 (-0.75%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
PRI   131.52 (-0.09%)
NFLX   305.16 (+0.85%)
BAC   32.69 (-0.76%)
GILD   64.88 (-0.18%)
DIS   146.93 (-0.98%)
Log in

InspireMD Stock Price, Forecast & Analysis (NYSEAMERICAN:NSPR)

$0.87
+0.03 (+3.57 %)
(As of 11/20/2019 04:00 PM ET)
Today's Range
$0.78
Now: $0.87
$0.88
50-Day Range
$1.34
MA: $2.42
$3.59
52-Week Range
$0.74
Now: $0.87
$12.00
Volume100,355 shs
Average Volume168,508 shs
Market Capitalization$1.22 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InspireMD, Inc, a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. Read More…

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:NSPR
Previous SymbolNASDAQ:NSPR
CUSIPN/A
Phone+1-857-4536553

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees43
Market Cap$1.22 million
Next Earnings Date2/18/2020 (Estimated)
OptionableNot Optionable

Receive NSPR News and Ratings via Email

Sign-up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.


InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions

What is InspireMD's stock symbol?

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

When did InspireMD's stock split? How did InspireMD's stock split work?

InspireMD shares reverse split on the morning of Monday, April 1st 2019. The 1-50 reverse split was announced on Tuesday, March 26th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, March 29th 2019. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 2 shares after the split.

How were InspireMD's earnings last quarter?

InspireMD Inc (NYSEAMERICAN:NSPR) issued its quarterly earnings results on Monday, August, 6th. The medical equipment provider reported ($7.50) EPS for the quarter. The medical equipment provider had revenue of $1 million for the quarter. View InspireMD's Earnings History.

When is InspireMD's next earnings date?

InspireMD is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for InspireMD.

What price target have analysts set for NSPR?

1 analysts have issued 12-month target prices for InspireMD's shares. Their forecasts range from $5.00 to $5.00. On average, they anticipate InspireMD's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 474.7% from the stock's current price. View Analyst Price Targets for InspireMD.

What is the consensus analysts' recommendation for InspireMD?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for InspireMD.

What are Wall Street analysts saying about InspireMD stock?

Here are some recent quotes from research analysts about InspireMD stock:
  • 1. According to Zacks Investment Research, "InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel. " (10/17/2019)
  • 2. HC Wainwright analysts commented, "Our $5 PT was derived by using a 25% weighted-average cost of capital to discount free cash flows we project 2019-2030, and dividing them by our projected number of shares for each year to account for the effects of share dilution, and then ascribing a 1% terminal growth rate and 75% probability of." (8/19/2019)

Has InspireMD been receiving favorable news coverage?

Headlines about NSPR stock have been trending neutral this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. InspireMD earned a daily sentiment score of 0.0 on InfoTrie's scale. They also assigned news articles about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for InspireMD.

Who are some of InspireMD's key competitors?

What other stocks do shareholders of InspireMD own?

Who are InspireMD's key executives?

InspireMD's management team includes the folowing people:
  • Dr. James J. Barry, Pres, CEO & Director (Age 60)
  • Mr. Craig Shore, CFO, Chief Admin. Officer, Sec. & Treasurer (Age 58)
  • Mr. Agustin V. Gago, Exec. VP & Chief Commercial Officer (Age 59)
  • Mr. Roei Samuri, VP of Operations
  • Dr. Sol J. Barer, Special Advisor to the Board (Age 72)

Who are InspireMD's major shareholders?

InspireMD's stock is owned by many different of institutional and retail investors. Top institutional investors include Wedbush Securities Inc. (2.14%). Company insiders that own InspireMD stock include Paul Stuka and Thomas J Kester. View Institutional Ownership Trends for InspireMD.

Which major investors are buying InspireMD stock?

NSPR stock was purchased by a variety of institutional investors in the last quarter, including Wedbush Securities Inc.. View Insider Buying and Selling for InspireMD.

How do I buy shares of InspireMD?

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is InspireMD's stock price today?

One share of NSPR stock can currently be purchased for approximately $0.87.

How big of a company is InspireMD?

InspireMD has a market capitalization of $1.22 million. InspireMD employs 43 workers across the globe.View Additional Information About InspireMD.

What is InspireMD's official website?

The official website for InspireMD is http://www.inspiremd.com/.

How can I contact InspireMD?

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.


MarketBeat Community Rating for InspireMD (NYSEAMERICAN NSPR)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  166 (Vote Outperform)
Underperform Votes:  162 (Vote Underperform)
Total Votes:  328
MarketBeat's community ratings are surveys of what our community members think about InspireMD and other stocks. Vote "Outperform" if you believe NSPR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSPR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Featured Article: What is a Swap?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel